Lon Schneider
Psychiatry · Los Angeles, CANPI 1922022201
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $139,188 of the $156,457 with a category attached, or 89.0%. 18 manufacturers reported payments, led by Eli Lilly at 27.0% of the total. Among psychiatry clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 99 payments — averaging $1580.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eli Lilly$42K
- Novo Nordisk$38K
- Otsuka Pharmaceutical Development & Commercialization, Inc.$11K
- Avid Radiopharmaceuticals, Inc.$10K
- Janssen Global Services, LLC$9K
- Eisai Inc.$7K
- plus $39K from 12 others
Across 60 payments — averaging $27,239 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$1.2M
- Novartis$252K
- Biogen$101K
- Genentech, Inc.$67K
- Biohaven Pharmaceutical Holding Company Ltd.$13K
- E.r. Squibb & Sons, L.L.C.$11K
- plus $306 from 1 others
What the payments were for
- Consulting fees$139,18889%
- Speaking & faculty fees$4,5003%
- Travel & lodging$10,8907%
- Food & beverage$1,8791%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Eli Lilly | 14 | $42,251 |
| Novo Nordisk | 26 | $38,094 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 9 | $10,845 |
| Avid Radiopharmaceuticals, Inc. | 4 | $9,782 |
| Janssen Global Services, LLC | 10 | $9,488 |
| Eisai Inc. | 9 | $7,428 |
| E.r. Squibb & Sons, L.L.C. | 6 | $6,448 |
| H. Lundbeck A S | 5 | $6,234 |
| GW Research Limited | 4 | $6,151 |
| Jazz Pharmaceuticals Inc. | 1 | $4,490 |
| Merck | 2 | $3,050 |
| Lilly USA, LLC | 1 | $2,900 |
| Boehringer Ingelheim International GmbH | 2 | $2,880 |
| Corium, LLC | 1 | $2,240 |
| Genentech USA, Inc. | 1 | $1,585 |
| UCB SA | 1 | $1,500 |
| AbbVie | 1 | $675 |
| Abbott | 2 | $415 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$156,457 in reported general payments places this provider in the 95th percentile of 4,954 psychiatry providers in California.
Other psychiatry in Los Angeles
- Jakub JurosLos Angeles$394K
- Derek OttLos Angeles$329K
- William WirshingLos Angeles$205K
- Gil HoftmanLos Angeles$200K
- Stephen MarderLos Angeles$103K
- John BrooksLos Angeles$80K
- Gustavo AlvaOrange$5.8M
- John KooSan Francisco$3M
- Jason KelloggIrvine$2.7M
- Jonathan MeyerSan Diego$2.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.